Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S E Gandy

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Investigative Ophthalmology & Visual Science|December 1, 1996
Beta-amyloid protein protein precursor expression in lacrimal glands and tear fluidG B Van Setten, L Nilsson, S Hahne, et al.
The Journal of Biological Chemistry|January 25, 1993
Proteolytic processing of human amyloid beta protein precursor in insect cells. Major carboxyl-terminal fragment is identical to its human counterpartT V Ramabhadran, S E Gandy, J Ghiso, et al.
Neuron|July 1, 1995
Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brainJ Näslund, J Thyberg, L O Tjernberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 1994
Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal agingJ Näslund, A Schierhorn, U Hellman, et al.
Molecular Psychiatry|September 17, 2002
Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein ES M Laws, E Hone, K Taddei, et al.
Neuroreport|April 20, 1999
The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's diseaseS M Laws, K Taddei, G Martins, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1990
Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylationJ D Buxbaum, S E Gandy, P Cicchetti, et al.
Annals of Neurology|December 1, 1990
General assay for phosphoproteins in cerebrospinal fluid: a candidate marker for paraneoplastic cerebellar degenerationS E Gandy, J A Grebb, N Rosen, et al.
Molecular Psychiatry|June 21, 2006
Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular diseaseI J Martins, E Hone, J K Foster, et al.
Neuroscience|April 27, 2010
The effect of APOE genotype on brain levels of oxysterols in young and old human APOE epsilon2, epsilon3 and epsilon4 knock-in miceA M Jenner, W L F Lim, M P E Ng, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Investigative Ophthalmology & Visual Science|December 1, 1996
Beta-amyloid protein protein precursor expression in lacrimal glands and tear fluidG B Van Setten, L Nilsson, S Hahne, et al.
The Journal of Biological Chemistry|January 25, 1993
Proteolytic processing of human amyloid beta protein precursor in insect cells. Major carboxyl-terminal fragment is identical to its human counterpartT V Ramabhadran, S E Gandy, J Ghiso, et al.
Neuron|July 1, 1995
Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brainJ Näslund, J Thyberg, L O Tjernberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 1994
Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal agingJ Näslund, A Schierhorn, U Hellman, et al.
Molecular Psychiatry|September 17, 2002
Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein ES M Laws, E Hone, K Taddei, et al.
Neuroreport|April 20, 1999
The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's diseaseS M Laws, K Taddei, G Martins, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1990
Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylationJ D Buxbaum, S E Gandy, P Cicchetti, et al.
Annals of Neurology|December 1, 1990
General assay for phosphoproteins in cerebrospinal fluid: a candidate marker for paraneoplastic cerebellar degenerationS E Gandy, J A Grebb, N Rosen, et al.
Molecular Psychiatry|June 21, 2006
Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular diseaseI J Martins, E Hone, J K Foster, et al.
Neuroscience|April 27, 2010
The effect of APOE genotype on brain levels of oxysterols in young and old human APOE epsilon2, epsilon3 and epsilon4 knock-in miceA M Jenner, W L F Lim, M P E Ng, et al.
Pageof 7